These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12886175)

  • 41. Image guided versus palpation guided core needle biopsy of palpable breast masses: a prospective study.
    Hari S; Kumari S; Srivastava A; Thulkar S; Mathur S; Veedu PT
    Indian J Med Res; 2016 May; 143(5):597-604. PubMed ID: 27488003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A systematic approach to the evaluation and management of breast masses.
    Winchester DP; Sener S; Immerman S; Blum M
    Cancer; 1983 Jun; 51(12 Suppl):2535-9. PubMed ID: 6850531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Palpable breast tumours: "triple diagnosis" and operative strategy. Results of a prospective study.
    Hermansen C; Skovgaard Poulsen H; Jensen J; Langfeldt B; Steenskov V; Frederiksen P; Myhre Jensen O
    Acta Chir Scand; 1984; 150(8):625-8. PubMed ID: 6532032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Investigation of palpable breast tumours. Patient flow and quality assessment of the tripple diagnostic procedure].
    Skaane P; Kåresen R; Jacobsen U; Amlie E; Sauer T; Skjørten F
    Tidsskr Nor Laegeforen; 1995 Jun; 115(16):1965-9. PubMed ID: 7638852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fine-needle aspiration (FNA) of palpable breast lesions.
    Herr VA
    S D J Med; 1994 Jul; 47(7):231-2. PubMed ID: 7939575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic reliability of combined physical examination, mammography, and fine-needle puncture ("triple-test") in breast tumors. A prospective study.
    Hermansen C; Skovgaard Poulsen H; Jensen J; Langfeldt B; Steenskov V; Frederiksen P; Jensen OM
    Cancer; 1987 Oct; 60(8):1866-71. PubMed ID: 3652014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperative diagnosis of carcinoma of the breast: Is a "cost-cutter" algorithm tenable?
    Chandawarkar RY; Shinde SR
    J Surg Oncol; 1997 Feb; 64(2):153-8. PubMed ID: 9047254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cost minimization approach to the diagnosis of skeletal neoplasms.
    Ruhs SA; el-Khoury GY; Chrischilles EA
    Skeletal Radiol; 1996 Jul; 25(5):449-54. PubMed ID: 8837276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective evaluation of the role of fine-needle aspiration biopsy in the diagnosis and management of patients with palpable solid breast lesions.
    Gelabert HA; Hsiu JG; Mullen JT; Jaffe AH; D'Amato NA
    Am Surg; 1990 Apr; 56(4):263-7. PubMed ID: 2163593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation.
    Ariga R; Bloom K; Reddy VB; Kluskens L; Francescatti D; Dowlat K; Siziopikou P; Gattuso P
    Am J Surg; 2002 Nov; 184(5):410-3. PubMed ID: 12433603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mammography after needle aspiration of palpable breast masses.
    Sickles EA; Klein DL; Goodson WH; Hunt TK
    Am J Surg; 1983 Mar; 145(3):395-7. PubMed ID: 6837868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative cost-effectiveness of fine needle aspiration biopsy versus image-guided biopsy, and open surgical biopsy in the evaluation of breast cancer in the era of Affordable Care Act: a changing landscape.
    Masood S; Rosa M; Kraemer DF; Smotherman C; Mohammadi A
    Diagn Cytopathol; 2015 Aug; 43(8):605-12. PubMed ID: 25722099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fine needle aspiration cytology, in relationships to clinical examination and mammography in the diagnosis of a solid breast mass.
    Dixon JM; Anderson TJ; Lamb J; Nixon SJ; Forrest AP
    Br J Surg; 1984 Aug; 71(8):593-6. PubMed ID: 6743977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The predictive value of three diagnostic procedures in the evaluation of palpable breast tumours.
    Crone P; Hertz J; Nilsson T; Junge J; Høier-Madsen K; Kennedy M; Bojsen-Møller J; Diepeveen P; Hahn-Pedersen A; Jørgensen SJ
    Ann Chir Gynaecol; 1984; 73(5):273-6. PubMed ID: 6524859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cost-effectiveness of fine-needle aspiration cytology and 14-gauge core needle biopsy compared with open surgical biopsy in the diagnosis of breast carcinoma.
    Logan-Young W; Dawson AE; Wilbur DC; Avila EE; Tomkiewicz ZM; Sheils LA; Laczin JA; Taylor AS
    Cancer; 1998 May; 82(10):1867-73. PubMed ID: 9587118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Critical review of 215 cases of non-palpable mammary lesions].
    Pastore G; Marano P; Romani M; Costantini M; Belli P
    Radiol Med; 1999 May; 97(5):344-8. PubMed ID: 10432964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. US-guided core breast biopsy: use and cost-effectiveness.
    Liberman L; Feng TL; Dershaw DD; Morris EA; Abramson AF
    Radiology; 1998 Sep; 208(3):717-23. PubMed ID: 9722851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Needle core biopsy guided with mammography: a study of cost-effectiveness.
    Lindfors KK; Rosenquist CJ
    Radiology; 1994 Jan; 190(1):217-22. PubMed ID: 8259408
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.